Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;6(10):573-82.
doi: 10.1038/nrneurol.2010.127. Epub 2010 Sep 7.

CGRP and its receptors provide new insights into migraine pathophysiology

Affiliations
Review

CGRP and its receptors provide new insights into migraine pathophysiology

Tony W Ho et al. Nat Rev Neurol. 2010 Oct.

Abstract

Over the past 300 years, the migraine field has been dominated by two main theories-the vascular theory and the central neuronal theory. The success of vasoconstrictors such as ergotamine and the triptans in treating acute migraine bolstered the vascular theory, but evidence is now emerging that vasodilatation is neither necessary nor sufficient to induce a migraine attack. Attention is now turning to the core migraine circuits in the brain, which include the trigeminal ganglia, trigeminal nucleus, medullary modulatory regions, pons, periaqueductal gray matter, hypothalamus and thalamus. Migraine triggers are likely to reflect a disturbance in overall balance of the circuits involved in the modulation of sensory activity, particularly those with relevance to the head. In this Review, we consider the evidence pointing towards a neuronal mechanism in migraine development, highlighting the role of calcitonin gene-related peptide (CGRP), which is found in small to medium-sized neurons in the trigeminal ganglion. CGRP is released during migraine attacks and can trigger migraine in patients, and CGRP receptor antagonists can abort migraine. We also examine whether other drugs, such as triptans, might exert their antimigraine effects via their actions on the neuronal circuit as opposed to the intracranial vasculature.

PubMed Disclaimer

References

    1. Cephalalgia. 1999 Oct;19(8):701-7 - PubMed
    1. Int J Clin Pract. 2005 Aug;59(8):961-8 - PubMed
    1. Eur J Neurosci. 1996 Apr;8(4):829-36 - PubMed
    1. Cephalalgia. 2008 Mar;28(3):226-36 - PubMed
    1. Ann Neurol. 1990 Aug;28(2):183-7 - PubMed

MeSH terms

Substances